Search alternatives:
mean decrease » a decrease (Expand Search)
ng decrease » nn decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
100 ng » 100 mg (Expand Search), 100 nm (Expand Search), 100 g (Expand Search)
mean decrease » a decrease (Expand Search)
ng decrease » nn decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
100 ng » 100 mg (Expand Search), 100 nm (Expand Search), 100 g (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Downregulation of activin A leads to a decrease in proliferation.
Published 2015“…<p>Treatment with recombinant activin A was not able to promote proliferation of HaCat cells, as revealed by bromodeoxyuridine (BrdU) incorporation index (A) and cell cycle analysis (B). (C) Follistatin at 100 ng/ml significantly blocked BrdU incorporation in SCC-9 ZsGreen LN-1 cells, but no effects on cell cycle distribution were observed (D). …”
-
8
-
9
-
10
-
11
Receptor specific silencing decreases NGF induced apoptosis.
Published 2013“…(E) Mean Fluorescence Intensity (MFI) specific for caspACE-VAD comparing 100 ng/mL NGF and 10 ng/mL TGFβ1 effects on control-siRNA, p75<sup>NTR</sup> siRNA and double trkA<sup>NGFR</sup>/p75<sup>NTR</sup> siRNA treated cells. …”
-
12
-
13
-
14
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…<b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. In HRMECs transfected with SUZ12 siRNA in HG, miR-200b was significantly increased with decreased levels of VEGF compared to HRMECs transfected with control siRNA, with levels similar to NG+control siRNA. …”
-
15
-
16
(R+S) and (R)-albuterol decrease NF-κB activity
Published 2011“…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”
-
17
-
18
-
19
-
20